Goal-Oriented Monitoring of Cyclosporine Is Effective for Graft-versus-Host Disease Prevention after Hematopoietic Stem Cell Transplantation in Sickle Cell Disease and Thalassemia Major-Reference-Cited by-同舟云学术

Goal-Oriented Monitoring of Cyclosporine Is Effective for Graft-versus-Host Disease Prevention after Hematopoietic Stem Cell Transplantation in Sickle Cell Disease and Thalassemia Major

Published:2020-12 Issue:12 Volume:26 Page:2285-2291
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Gauthier Alexandra,Bleyzac Nathalie,Garnier Nathalie,Kebaili Kamila,Joly Philippe^ORCID,Goutagny Marie-Pierre,Mollet Isabelle,Goutelle Sylvain^ORCID,Renard Cécile,Bertrand Yves

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference38 articles.

1. Marrow transplantation for thalassaemia;Thomas;Lancet,1982

2. Bone-marrow transplantation in a patient with sickle-cell anemia;Johnson;N Engl J Med,1984

3. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease;Bernaudin;Blood,2007

4. Gene therapy for hemoglobinopathies;Cavazzana;Hum Gene Ther,2018

5. Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel;Angelucci;Haematologica,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent results of hematopoietic stem cell transplantation for thalassemia with busulfan-based conditioning regimen in France: improved thalassemia free survival despite frequent mixed chimerism. A retrospective study from the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC);Bone Marrow Transplantation;2023-08-04

2. Impact of a Bayesian Individualization of Cyclosporine Dosage Regimen for Children Undergoing Allogeneic Hematopoietic Cell Transplantation: A Cost-Effectiveness Analysis;Therapeutic Drug Monitoring;2021-08

3. TRough versus AUC Monitoring of cyclosporine: A randomized comparison of adverse drug reactions in adult allogeneic stem cell recipients (TRAM study);European Journal of Haematology;2021-06-23